Cryo-Cell has rejected a $17.63 million takeover bid from DW Healthcare Partners. DW Healthcare has offered to buy Cryo-Cell for $1.50 a share, representing a 67% premium to the company’s Friday closing stock price. Cryo-Cell’s board has determined that the offer is “inadequate and believes that it significantly undervalues the company and its growth prospects,” according to a statement. Oldsmar, Fla.-based Cryo-Cell operates a cord blood bank services. DW Healthcare, of Park City, Utah, is a healthcare focused PE firm.